Entrepreneurship education is the core mission of the Grid. Through our course offering, we help students become entrepreneurial thinkers and doers. We work with students to create ideas, test out innovations and bring ideas to market.
Entrepreneurship in Life Sciences ▾
This course is open to all graduate students and post-doctoral fellows. Students will explore the development of a life sciences start-up venture, and in some cases, begin to create their own start-up ventures. Students will learn how to assess the feasibility of a life science start-up venture, evaluate financial and market opportunities, explore the customer discovery process, author a business plan, and build financial projections. Students will discuss a wide range of issues of importance and concern to life science entrepreneurs and learn to recognize opportunity, assess the skills and talents of successful entrepreneurs, network with life science entrepreneurs, learn models and approaches that help them analyze entrepreneurial opportunities throughout their career. Successful life science entrepreneurs will highlight real world experiences in guest lectures.
- To learn methods to evaluate life science based technology and intellectual property as basis of new venture creation
- To study the knowledge, skills and attitudes required for entrepreneurship
- To evaluate market, operational and financial feasibility of venture formation
- To learn basic business planning and financial planning skills
- To network with life science entrepreneurs
- To provide students with the skills for identifying and analyzing entrepreneurial opportunities throughout their career
Statement of Confidentiality
Throughout the course, students will be exposed to proprietary information from other students, guest lecturers and faculty. All such information is to be treated as confidential. By enrolling in and taking part in this course, students agree not to disclose this information to any third parties without the specific written permission from students, guest lecturers or faculty as applicable. Students further agree not to utilize any such proprietary information for their own personal commercial advantage or for the commercial advantage of any third party. In additions, students agree that any advice provided by the instructor and any affiliated parties will not serve as the basis on any legal suit. Any breach of this policy may subject a student to academic integrity proceedings as described in the University of Maryland policies and procedures, and to any remedies that may be available at law. Receipt of this policy and registration in our classes is evidence that you understand this policy and will abide by it.
Register on the SURFS website at www.umaryland.edu/surfs
CRN Number 26474
- “Technology Ventures” by Richard C. Dorf and Thomas H. Byers. 1st or 2nd edition is the optional text. Listed as Dorf & Byers in the schedule.
- Articles and readings as assigned
- Interim assignments (5% per sub-item) 25%
- Concept submission (team)
- Market and competitive analysis (team)
- Regulatory, ethics and operations statement (team)
- Marketing plan (team)
- Financial statements (team)
- Business Plan (team) 25%
- Investor Presentation (team) 20%
- Class participation (individual) 10%
- Peer evaluation (individual) 10%
- Investor feedback (individual) 10%
Instructor - Rana Quraishi, PhD
Professional Background and Experience
Director of New Ventures UMB
- Create startups from appropriate University IP, develop business strategy and function as senior management at startups and obtain funding.
- Developed UMB’s New Venture Initiative (NVI) approved by Board of Regents
- Manage NVI team and consultants
- Maintain extensive relationships with major national venture firms, angel groups, and external innovation teams at pharma companies
- Run Presidential Entrepreneurial Fellowship program
- Senior Advisor at TCG Group, a premiere private equity firm focused on business development opportunities for its life science companies
- Principal at Conning Capital Partners/SwissRe an early stage private equity fund providing growth capital for entrepreneurial companies - served on Boards of several portfolio companies.
- CFO/senior advisor for Helicon Therapeutics, a start-up with assets contributed by Cold Spring Harbor and OSI Pharmaceuticals - developed business plan, obtained full funding for plan.
- Senior roles in acquisitions, treasury and risk at Standard and Poor’s, GE Capital, J.E. Seagram and American Express
- Authored “Market Demand Study for Commercial Biotechnology, Biomedical, and Bioinformatics Facilities in New York City” for New York City Partnership and Investment Fund.
- Taught Biochemistry and Genetics at Columbia University during PhD, subsequently guest lecturer at academic institutions
- PhD in Molecular Biology and Biochemistry - Columbia University, BA - Columbia (Barnard), Master Degree - Harvard University.